Austin Film Festival Puts Claymation Magic Into The Hands of Young Patients

In a visit last week, the Austin Film Festival put the power of filmmaking into the hands of some awed patients at the Children's Blood and Cancer Center at Dell Children's Hospital.

The staff from AFF was able to give some of the kids at the CBCC a chance to make their own movies while also giving them a much-needed chance to think about something other than their illnesses.

Each claymation film began at the clay table, where kids were encouraged to build their own characters from clay.

Amplify Austin to benefit CBCC

AFF, which already sponsors the CBCC's Teen Infusion Room, will participate in this year's Amplify Austin on behalf of the CBCC. Amplify Austin is a 24 hour fundraiser based on the premise, "I live here, I give here." It's a 'festival of giving' that allows for nonprofits of all sizes to reach the interests of Austinites who can then support them through donations.

All proceeds donated to AFF on March 20 and 21 during Amplify Austin will benefit the CBCC's Teen Infusion Room. AFF hopes to "bring awareness of the CBCC to the community and ultimately help create the best environment possible for kids with life-threatening disease."

Recently, AFF's Executive Director Barbara Morgan recounted her long and fulfilling relationship with the CBCC, and AFF's Senior Film Programmer Liz Mims blogged about claymation, the CBCC and Amplify Austin over at AFF's home page.

[All photo credits: Ross Bonander. For more pictures, visit the CBCC's Facebook album or my smugmug page.]
...

This is the tenth installment in my series on the Children's Blood and Cancer Center at Dell Children's Hospital in Austin, Texas. The prior nine are listed below:

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap